Article
In vitro evaluation of global coagulation potential in the copresence of emicizumab and warfarin in whole blood using rotational thromboelastometry
2025-02-17
Abstract excerpt
<h4>Background: </h4> : Warfarin inhibits the generation of vitamin K-dependent proteins. Emicizumab can prevent bleeding episodes in persons with hemophilia A (PwHA). The hemostatic potential of emicizumab combined with warfarin in PwHA remains to be clarified. <h4>Aim: </h4> : To assess the coagulation of emicizumab combined with warfarin in a simulated whole blood model of PwHA. <h4>Methods: </h4> : We collec...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a4e93cfb-1652-5cf2-8159-b0be1cbf9a1f
- DOI
- 10.22541/au.173977041.11124252/v1
